The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Metabolomic profiling to develop blood biomarkers for Parkinson's disease
Open accessAbstract
The development of biomarkers for the diagnosis and monitoring disease progression in Parkinson's disease (PD) is of great importance since diagnosis based on clinical parameters has a considerable error rate. In this study, we utilized metabolomic profiling using high performance liquid chromatography coupled with electrochemical coulometric array detection (LCECA) to look for biomarkers in plasma useful for the diagnosis of PD. We examined 25 controls and 66 PD patients. We also measured 8-hydroxy-2-deoxyguanosine (8-OHdG) levels as a marker of oxidative damage to DNA. We initially examined the profiles of unmedicated PD subjects compared to controls to rule out confounding effects of symptomatic medications. We found a complete separation of the two groups. We then determined the variables, which played the greatest role in separating the two groups and applied them to PD subjects taking dopaminergic medications. Using these parameters, we achieved a complete separation of the PD patients from controls. 8-OHdG levels were significantly increased in PD patients, but overlapped controls. Two other markers of oxidative damage were measured in our LCECA profiles. Uric acid was significantly reduced while glutathione was significantly increased in PD patients. These findings show that metabolomic profiling with LCECA coulometric array has great promise for developing biomarkers for both the diagnosis, as well as monitoring disease progression in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Self-citationMetabonomics: a platform for studying drug toxicity and gene function
Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd728 · Cited by 1,914
Hughes, A. J., Ben-Shlomo, Y., Daniel, S. E., & Lees, A. J. (1992) · Neurology · doi:10.1212/wnl.42.6.1142 · Cited by 1,313
Metabolomics by numbers: acquiring and understanding global metabolite data
Goodacre, R., Vaidyanathan, S., Dunn, W. B., Harrigan, G. G., & Kell, D. B. (2004) · Trends in Biotechnology · doi:10.1016/j.tibtech.2004.03.007 · Cited by 1,249
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810153391607 · Cited by 1,201
Abnormalities of the electron transport chain in idiopathic parkinson's disease
Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,063
Brindle, J. T., Antti, H., Holmes, E., Tranter, G., Nicholson, J. K., Bethell, H. W. L., Clarke, S., Schofield, P. M., McKilligin, E., Mosedale, D. E., et al. (2002) · Nature Medicine · doi:10.1038/nm1202-802 · Cited by 1,029
Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline
Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984
Expression of Nrf2 in Neurodegenerative Diseases
Ramsey, C. P., Glass, C. A., Montgomery, M. B., Lindl, K. A., Ritson, G. P., Chia, L. A., Hamilton, R. L., Chu, C. T., & Jordan-Sciutto, K. L. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31802d6da9 · Cited by 760
Multi- and megavariate data analysis
Eriksson, L. (2006) · Cited by 736
El‐Agnaf, O. M. A., Salem, S. A., Paleologou, K. E., Curran, M. D., Gibson, M. J., Court, J. A., Schlossmacher, M. G., & Allsop, D. (2006) · The FASEB Journal · doi:10.1096/fj.03-1449com · Cited by 715
Molecular markers of early Parkinson's disease based on gene expression in blood
Scherzer, C. R., Eklund, A. C., Morse, L. J., Liao, Z., Locascio, J. J., Fefer, D., Schwarzschild, M. A., Schlossmacher, M. G., Hauser, M. A., Vance, J. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610204104 · Cited by 512
Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia
Sabatine, M. S., Liu, E., Morrow, D. A., Heller, E., McCarroll, R., Wiegand, R., Berriz, G. F., Roth, F. P., & Gerszten, R. E. (2005) · Circulation · doi:10.1161/circulationaha.105.569137 · Cited by 461
The NINDS NET-PD Investigators (2006) · Neurology · doi:10.1212/01.wnl.0000201252.57661.e1 · Cited by 453
Haas, R. H., Nasirian, F., Nakano, K., Ward, D., Pay, M., Hill, R., & Shults, C. W. (1995) · Annals of Neurology · doi:10.1002/ana.410370604 · Cited by 435
Tokuda, T., Salem, S. A., Allsop, D., Mizuno, T., Nakagawa, M., Qureshi, M. M., Locascio, J. J., Schlossmacher, M. G., & El-Agnaf, O. M. A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.024 · Cited by 425
Platelet mitochondria function in Parkinson's disease
Krige, D., Carroll, M. T., Cooper, J. M., Marsden, C. D., Schapira, A. H. V., & (The Royal Kings Queens Parkinson Disease Research Group) (1992) · Annals of Neurology · doi:10.1002/ana.410320612 · Cited by 352
Mitochondrial oxidative phosphorylation defects in parkinson's disease
Shoffner, J. M., Watts, R. L., Juncos, J. L., Torroni, A., & Wallace, D. C. (1991) · Annals of Neurology · doi:10.1002/ana.410300304 · Cited by 333
Detection of epithelial ovarian cancer using 1H‐NMR‐based metabonomics
Odunsi, K., Wollman, R. M., Ambrosone, C. B., Hutson, A., McCann, S. E., Tammela, J., Geisler, J. P., Miller, G., Sellers, T., Cliby, W., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.20651 · Cited by 317
Serum uric acid levels and the risk of Parkinson disease
de Lau, L. M. L., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20663 · Cited by 301
Holmes, E., Tsang, T. M., Huang, J. T.-J., Leweke, F. M., Koethe, D., Gerth, C. W., Nolden, B. M., Gross, S., Schreiber, D., Nicholson, J. K., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030327 · Cited by 290
Kikuchi, A., Takeda, A., Onodera, H., Kimpara, T., Hisanaga, K., Sato, N., Nunomura, A., Castellani, R. J., Perry, G., Smith, M. A., et al. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0466 · Cited by 289
Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease
Bindoff, L. A., Birch-Machin, M. A., Cartlidge, N. E. F., Parker, W. D., & Turnbull, D. M. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90311-t · Cited by 229
Multi- and Megavariate Data Analysis
Nemeth, M. A. (2003) · Technometrics · doi:10.1198/tech.2003.s162 · Cited by 226
YANG, J., XU, G., ZHENG, Y., KONG, H., PANG, T., LV, S., & YANG, Q. (2004) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.09.032 · Cited by 210
Brindle, J. T., Nicholson, J. K., Schofield, P. M., Grainger, D. J., & Holmes, E. (2003) · The Analyst · doi:10.1039/b209155k · Cited by 191
Pankratz, N., Nichols, W. C., Uniacke, S. K., Halter, C., Rudolph, A., Shults, C., Conneally, P. M., & Foroud, T. (2002) · The American Journal of Human Genetics · doi:10.1086/341282 · Cited by 183
Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles
Underwood, B. R., Broadhurst, D., Dunn, W. B., Ellis, D. I., Michell, A. W., Vacher, C., Mosedale, D. E., Kell, D. B., Barker, R. A., Grainger, D. J., et al. (2006) · Brain · doi:10.1093/brain/awl027 · Cited by 183
Bogdanov, M. B., Beal, M. F., McCabe, D. R., Griffin, R. M., & Matson, W. R. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00113-6 · Cited by 179
Self-citationMetabolomic analysis and signatures in motor neuron disease
Rozen, S., Cudkowicz, M., Bogdanov, M. B., Matson, W. R., Kristal, B. S., Beecher, C., Harrison, S. J., Vouros, P., Flarakos, J., Vigneau-Callahan, K. E., et al. (2005) · Metabolomics · doi:10.1007/s11306-005-4810-1 · Cited by 146
Self-citationUrinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease
Sato, S., Mizuno, Y., & Hattori, N. (2005) · Neurology · doi:10.1212/01.wnl.0000154597.24838.6b · Cited by 124
Yang, J., Xu, G., HONG, Q., LIEBICH, H., Lutz, K., Schmülling, R., & Wahl, H. G. ̈. (2004) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.09.023 · Cited by 111
Metabolomic applications of electrochemistry/Mass spectrometry
Gamache, P. H., Meyer, D. F., Granger, M. C., & Acworth, I. N. (2004) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2004.08.016 · Cited by 103
Peripheral Blood Markers of Oxidative Stress in Parkinson’s Disease
Younes, S., Frih-Ayed, M., Kerkeni, A., Bost, M., & Chazot, G. (2007) · European Neurology · doi:10.1159/000103641 · Cited by 97
EC array sensor concepts and data
Matson, W. R., Gamache, P. G., Beal, M. F., & Bird, E. D. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90192-5 · Cited by 91
Self-citationPenn, A. M. W., Roberts, T., Hodder, J., Allen, P. S., Zhu, G., & Martin, W. R. W. (1995) · Neurology · doi:10.1212/wnl.45.11.2097 · Cited by 80
Vigneau-Callahan, K. E., Shestopalov, A. I., Milbury, P. E., Matson, W. R., & Kristal, B. S. (2001) · Journal of Nutrition · doi:10.1093/jn/131.3.924s · Cited by 73
Self-citationChildren with Type 2 Diabetes: The Risks of Complications
Matthews, D. R., & Wallace, T. M. (2002) · Hormone Research in Paediatrics · doi:10.1159/000053310 · Cited by 44
Shi, H., Vigneau-Callahan, K. E., Matson, W. R., & Kristal, B. S. (2002) · Analytical Biochemistry · doi:10.1006/abio.2001.5568 · Cited by 37
Self-citationNeuroimaging trials of Parkinson?s disease progression
Seibyl, J. P., Jennings, D. L., Tabamo, R. E., & MAREK, K. L. (2004) · Journal of Neurology · doi:10.1007/s00415-004-1704-5 · Cited by 32
Iodized Oil as a Complement to Iodized Salt in Schoolchildren in Endemic Goiter in Romania
Simescu, M., Varciu, M., Nicolaescu, E., Gnat, D., Podoba, J., Mihaescu, M., & Delange, F. M. (2002) · Hormone Research in Paediatrics · doi:10.1159/000064657 · Cited by 16
PLATELET MITOCHONDRIAL-FUNCTION IN PARKINSONS-DISEASE
Krige, D., CARROLL, M., Cooper, J. A. D., MARSDEN, C., & Schapira, A. H. V. (1992) · UCL Discovery (University College London) · Cited by 12
Cited by
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
The Human Serum Metabolome (HUSERMET) Consortium, Dunn, W. B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIntyre, S., Anderson, N., Brown, M., Knowles, J. D., Halsall, A., et al. (2011) · Nature Protocols · doi:10.1038/nprot.2011.335 · Cited by 3,294
Han, X., Rozen, S., Boyle, S. H., Hellegers, C., Cheng, H., Burke, J. R., Welsh-Bohmer, K. A., Doraiswamy, P. M., & Kaddurah-Daouk, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021643 · Cited by 429
Biomarkers of Parkinson’s disease: Present and future
Miller, D. B., & O’Callaghan, J. P. (2015) · Metabolism · doi:10.1016/j.metabol.2014.10.030 · Cited by 358
The dynamic range of the human metabolome revealed by challenges
Krug, S., Kastenmüller, G., Stückler, F., Rist, M. J., Skurk, T., Sailer, M., Raffler, J., Römisch‐Margl, W., Adamski, J., Prehn, C., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-198093 · Cited by 327
Metadata
- Authors
- Bogdanov, M., Matson, W. R., Wang, L., Matson, T., Saunders-Pullman, R., Bressman, S. S., & Beal, M. F.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-02-01
- Volume
- 131
- Issue
- 2
- Pages
- 389-396
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2117524242
- Cited by
- 401
- References
- 43
- FWCI
- 20.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.